| Lead Author | Presentation Type | Title | Presentation Date | Time | Location |
| Shiwei Liu, PhD | Oral | Integration of GWAS summary statistics with cell type-specific eQTLs prioritizes potential causal genes for Alzheimer’s disease | 07/28/24 | 9:00am – 9:07am ET | Nutter Theater – Pennsylvania Convention Center |
| Joseph Reddy | Poster | Multi-omics profiling of Alzheimer’s disease in multi-ethnic populations | 07/29/24 | 8:00am – 4:15pm ET | Exhibit Hall (Hall BC) – Pennsylvania Convention Center |
| Lindsey Kuchenbecker | Poster | Untargeted plasma proteomics nominates a novel set of plasma biomarkers for Alzheimer’s disease in African Americans. | 07/30/24 | 8:00am – 4:15pm ET | Exhibit – Pennsylvania Convention Center |
| Adelyn Tsai | Poster | Discovery of Genes Underlying Cognitive Resilience in Individuals Predisposed to Alzheimer’s Disease Risk | 07/31/24 | 8:00am – 4:15pm ET | Exhibit Hall (Hall BC) – Pennsylvania Convention Center |
| Xuan Chen | Poster | Blood-based gene and co-expression network levels are associated with AD/MCI diagnosis and cognitive phenotypes | 07/31/24 | 8:00am – 4:15pm ET | Exhibit Hall (Hall BC) – Pennsylvania Convention Center |
| Samantha Strickland | Featured Research Session | Preserved transcriptional networks in immune signaling pathways associated with chronic disease identified in Alzheimer’s disease and Parkinson’s disease, cross-tissue analysis | 08/01/24 | 10:30am – 10:40am ET | 121 ABC – Pennsylvania Convention Center |
| Thea J. Rosewood | Poster | Pathway Enrichment of Longitudinal AD Endophenotypes Identifies Potential Therapeutic Targets for Modifying Disease Trajectory | | | |
| Andy Saykin | Oral | Session 4: Enabling Precision Medicine for AD/ADRD: From Cohort Studies to Clinical Trials | 07/26/24 | 9:45am – 11:15 am ET | Marriott (Grand Ballrooms G,K,L) |
